Royal Bank of Canada’s Albany Molecular Research Inc AMRI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | – | Sell |
-34,476
| Closed | -$748K | – | 6390 |
|
2017
Q2 | $748K | Sell |
34,476
-6,144
| -15% | -$133K | ﹤0.01% | 2750 |
|
2017
Q1 | $571K | Sell |
40,620
-3,320
| -8% | -$46.7K | ﹤0.01% | 2974 |
|
2016
Q4 | $825K | Buy |
43,940
+635
| +1% | +$11.9K | ﹤0.01% | 2681 |
|
2016
Q3 | $716K | Sell |
43,305
-1,148
| -3% | -$19K | ﹤0.01% | 2772 |
|
2016
Q2 | $597K | Buy |
44,453
+611
| +1% | +$8.21K | ﹤0.01% | 2935 |
|
2016
Q1 | $670K | Buy |
43,842
+7,568
| +21% | +$116K | ﹤0.01% | 2845 |
|
2015
Q4 | $719K | Sell |
36,274
-982
| -3% | -$19.5K | ﹤0.01% | 2822 |
|
2015
Q3 | $650K | Buy |
37,256
+1,808
| +5% | +$31.5K | ﹤0.01% | 2739 |
|
2015
Q2 | $717K | Buy |
35,448
+1,452
| +4% | +$29.4K | ﹤0.01% | 2793 |
|
2015
Q1 | $598K | Buy |
33,996
+1,096
| +3% | +$19.3K | ﹤0.01% | 2917 |
|
2014
Q4 | $536K | Hold |
32,900
| – | – | ﹤0.01% | 2966 |
|
2014
Q3 | $726K | Sell |
32,900
-260
| -0.8% | -$5.74K | ﹤0.01% | 2634 |
|
2014
Q2 | $667K | Sell |
33,160
-30
| -0.1% | -$603 | ﹤0.01% | 2744 |
|
2014
Q1 | $617K | Buy |
33,190
+1,640
| +5% | +$30.5K | ﹤0.01% | 2747 |
|
2013
Q4 | $318K | Sell |
31,550
-3,144
| -9% | -$31.7K | ﹤0.01% | 3206 |
|
2013
Q3 | $447K | Buy |
34,694
+594
| +2% | +$7.65K | ﹤0.01% | 2961 |
|
2013
Q2 | $405K | Buy |
+34,100
| New | +$405K | ﹤0.01% | 2817 |
|